Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for AVXL

Stock Name	Anavex Life Sciences Corp
Ticker	AVXL(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US0327973006
LEI	549300K1I5L8COCQ8W36

Show aggregate AVXL holdings

News associated with AVXL

D. Boral Capital Reiterates Buy Rating for Anavex Life Sciences (NASDAQ:AVXL): Anavex Life Sciences (NASDAQ:AVXL – Get Free Report)‘s stock had its “buy” rating restated by research analysts at D. Boral Capital in a research report issued on Wednesday,Benzinga reports. They presently have a $46.00 price objective on the biotechnology company’s stock. D. Boral Capital’s price objective indicates a potential upside of 380.17% from the company’s […] - 2025-09-12 03:00:45
Anavex Life Sciences (NASDAQ:AVXL) Receives Buy Rating from HC Wainwright: HC Wainwright reissued their buy rating on shares of Anavex Life Sciences (NASDAQ:AVXL – Free Report) in a report released on Wednesday morning,Benzinga reports. They currently have a $42.00 target price on the biotechnology company’s stock. Other research analysts have also issued research reports about the stock. Wall Street Zen lowered shares of Anavex Life […] - 2025-09-11 04:46:19
Anavex Life Sciences (NASDAQ:AVXL) Given “Buy” Rating at HC Wainwright: HC Wainwright reiterated their buy rating on shares of Anavex Life Sciences (NASDAQ:AVXL – Free Report) in a research report sent to investors on Friday morning,Benzinga reports. The firm currently has a $42.00 price target on the biotechnology company’s stock. Separately, D. Boral Capital reaffirmed a “buy” rating and issued a $46.00 price target on […] - 2025-08-25 02:12:48
Sheaff Brock Investment Advisors LLC Sells 4,500 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL): Sheaff Brock Investment Advisors LLC decreased its stake in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 28.6% during the first quarter, Holdings Channel.com reports. The institutional investor owned 11,250 shares of the biotechnology company’s stock after selling 4,500 shares during the quarter. Sheaff Brock Investment Advisors LLC’s holdings in Anavex Life Sciences were […] - 2025-07-30 05:17:01
Arizona State Retirement System Takes $208,000 Position in Anavex Life Sciences Corp. (NASDAQ:AVXL): Arizona State Retirement System acquired a new position in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 24,297 shares of the biotechnology company’s stock, valued at approximately $208,000. A number of other institutional investors and hedge […] - 2025-07-23 04:54:53
Alps Advisors Inc. Sells 8,346 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL): Alps Advisors Inc. cut its holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 12.2% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 60,220 shares of the biotechnology company’s stock after selling 8,346 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-15 06:26:00
Critical Survey: Anavex Life Sciences (NASDAQ:AVXL) & Beyond Air (NASDAQ:XAIR): Beyond Air (NASDAQ:XAIR – Get Free Report) and Anavex Life Sciences (NASDAQ:AVXL – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, earnings, dividends and risk. Valuation & Earnings This table compares […] - 2025-07-14 02:41:00
Cetera Investment Advisers Takes $150,000 Position in Anavex Life Sciences Corp. (NASDAQ:AVXL): Cetera Investment Advisers bought a new stake in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 14,001 shares of the biotechnology company’s stock, valued at approximately $150,000. Several other hedge […] - 2025-06-03 06:22:58
Squarepoint Ops LLC Boosts Stock Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL): Squarepoint Ops LLC raised its holdings in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 304.9% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 67,627 shares of the biotechnology company’s stock after purchasing an additional 50,924 shares during the period. Squarepoint Ops LLC owned […] - 2025-06-03 05:38:51
Bank of America Corp DE Has $2.14 Million Stock Position in Anavex Life Sciences Corp. (NASDAQ:AVXL): Bank of America Corp DE cut its stake in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 27.8% in the 4th quarter, HoldingsChannel.com reports. The firm owned 198,780 shares of the biotechnology company’s stock after selling 76,485 shares during the quarter. Bank of America Corp DE’s holdings in Anavex Life Sciences were worth $2,135,000 […] - 2025-06-03 05:04:52
MetLife Investment Management LLC Has $496,000 Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL): MetLife Investment Management LLC grew its holdings in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 14.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 46,177 shares of the biotechnology company’s stock after acquiring an additional 5,816 […] - 2025-05-06 05:01:07
AlphaQuest LLC Acquires Shares of 13,626 Anavex Life Sciences Corp. (NASDAQ:AVXL): AlphaQuest LLC acquired a new stake in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 13,626 shares of the biotechnology company’s stock, valued at approximately $146,000. Several other hedge funds and […] - 2025-03-18 06:06:52
19,558 Shares in Anavex Life Sciences Corp. (NASDAQ:AVXL) Bought by Proficio Capital Partners LLC: Proficio Capital Partners LLC bought a new position in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) in the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 19,558 shares of the biotechnology company’s stock, valued at approximately $210,000. Several other hedge funds and other institutional investors have also recently modified their holdings of […] - 2025-03-13 05:14:57
Y Intercept Hong Kong Ltd Buys New Position in Anavex Life Sciences Corp. (NASDAQ:AVXL): Y Intercept Hong Kong Ltd purchased a new position in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) during the 4th quarter, HoldingsChannel reports. The firm purchased 22,631 shares of the biotechnology company’s stock, valued at approximately $243,000. Other large investors also recently made changes to their positions in the company. Barclays PLC lifted its […] - 2025-03-05 08:19:04
Anavex Life Sciences (NASDAQ:AVXL) vs. Cortexyme (NASDAQ:CRTX) Financial Survey: Anavex Life Sciences (NASDAQ:AVXL – Get Free Report) and Cortexyme (NASDAQ:CRTX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and profitability. Valuation & Earnings This table compares Anavex […] - 2025-02-28 05:00:47
HC Wainwright Reiterates Buy Rating for Anavex Life Sciences (NASDAQ:AVXL): Anavex Life Sciences (NASDAQ:AVXL – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. They presently have a $42.00 price target on the biotechnology company’s stock. HC Wainwright’s price objective would indicate a potential upside of 382.48% from the […] - 2025-02-20 05:14:43
Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Purchased by China Universal Asset Management Co. Ltd.: China Universal Asset Management Co. Ltd. boosted its holdings in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 10.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 17,980 shares of the biotechnology company’s stock after acquiring […] - 2025-02-04 07:46:55
SG Americas Securities LLC Has $374,000 Position in Anavex Life Sciences Corp. (NASDAQ:AVXL): SG Americas Securities LLC lifted its stake in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 25.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 34,844 shares of the biotechnology company’s stock after buying an additional 7,138 shares during the period. […] - 2025-02-04 06:55:00

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc AVXL holdings

Date	Number of AVXL Shares Held	Base Market Value of AVXL Shares	Local Market Value of AVXL Shares	Change in AVXL Shares Held	Change in AVXL Base Value	Current Price per AVXL Share Held	Previous Price per AVXL Share Held
2025-09-26 (Friday)	64,282	USD 556,682	USD 556,682
2025-09-25 (Thursday)	64,282	USD 546,397	USD 546,397	0	USD 3,857	USD 8.5	USD 8.44
2025-09-24 (Wednesday)	64,282	USD 542,540	USD 542,540
2025-09-17 (Wednesday)	63,864	USD 560,726	USD 560,726	0	USD -11,495	USD 8.78	USD 8.95999
2025-09-16 (Tuesday)	63,864	USD 572,221	USD 572,221
2025-09-12 (Friday)	63,446	USD 594,489	USD 594,489
2025-09-11 (Thursday)	63,446	USD 607,813	USD 607,813

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of AVXL by Blackrock for IE00B3VWM098

Show aggregate share trades of AVXL

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-08-21 SELL -156 9.550* 9.12 Profit of 1,423 on sale
2025-07-31 BUY 468 11.300* 9.09
2025-06-30 SELL -312 9.220* 8.67 Profit of 2,706 on sale
2025-06-25 SELL -156 9.410* 8.64 Profit of 1,348 on sale
2025-06-23 BUY 9,935 9.300* 8.62
2025-06-20 SELL -244 9.090* 8.62 Profit of 2,103 on sale
2025-05-23 BUY 122 7.530* 8.82
2025-05-19 SELL -122 8.440* 8.90 Profit of 1,085 on sale
2025-05-15 SELL -366 8.370* 8.92 Profit of 3,263 on sale
2025-05-12 SELL -122 8.550* 8.96 Profit of 1,093 on sale
2025-05-09 SELL -122 8.250* 8.97 Profit of 1,094 on sale
2025-04-30 SELL -122 9.500* 8.98 Profit of 1,096 on sale
2025-04-24 SELL -244 9.450* 8.92 Profit of 2,177 on sale
2025-04-17 SELL -122 8.950* 8.90 Profit of 1,086 on sale
2025-04-15 SELL -366 9.120* 8.90 Profit of 3,257 on sale
2025-04-14 SELL -366 8.820* 8.90 Profit of 3,258 on sale
2025-04-10 BUY 9,962 8.540* 8.92
2025-04-09 SELL -356 8.720* 8.93 Profit of 3,177 on sale
2025-04-07 SELL -623 8.330* 9.01 Profit of 5,610 on sale
2025-04-04 SELL -890 8.190* 9.04 Profit of 8,046 on sale
2025-03-31 BUY 89 8.580* 9.14
2025-03-19 SELL -178 9.840* 8.87 Profit of 1,579 on sale
2025-03-14 SELL -534 9.430* 8.73 Profit of 4,660 on sale
2025-03-13 SELL -178 9.000* 8.69 Profit of 1,547 on sale
2025-03-12 SELL -3,026 8.900* 8.66 Profit of 26,214 on sale
2025-03-07 BUY 1,184 8.670* 8.50
2025-03-06 BUY 9,510 8.590* 8.47
2025-03-05 BUY 1,951 8.730* 8.34
2025-03-04 BUY 645 8.410* 8.27
2025-03-03 BUY 3,515 8.270* 0.00
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-08-21	SELL	-156	9.550*	9.12 Profit of 1,423 on sale
2025-07-31	BUY	468	11.300*	9.09
2025-06-30	SELL	-312	9.220*	8.67 Profit of 2,706 on sale
2025-06-25	SELL	-156	9.410*	8.64 Profit of 1,348 on sale
2025-06-23	BUY	9,935	9.300*	8.62
2025-06-20	SELL	-244	9.090*	8.62 Profit of 2,103 on sale
2025-05-23	BUY	122	7.530*	8.82
2025-05-19	SELL	-122	8.440*	8.90 Profit of 1,085 on sale
2025-05-15	SELL	-366	8.370*	8.92 Profit of 3,263 on sale
2025-05-12	SELL	-122	8.550*	8.96 Profit of 1,093 on sale
2025-05-09	SELL	-122	8.250*	8.97 Profit of 1,094 on sale
2025-04-30	SELL	-122	9.500*	8.98 Profit of 1,096 on sale
2025-04-24	SELL	-244	9.450*	8.92 Profit of 2,177 on sale
2025-04-17	SELL	-122	8.950*	8.90 Profit of 1,086 on sale
2025-04-15	SELL	-366	9.120*	8.90 Profit of 3,257 on sale
2025-04-14	SELL	-366	8.820*	8.90 Profit of 3,258 on sale
2025-04-10	BUY	9,962	8.540*	8.92
2025-04-09	SELL	-356	8.720*	8.93 Profit of 3,177 on sale
2025-04-07	SELL	-623	8.330*	9.01 Profit of 5,610 on sale
2025-04-04	SELL	-890	8.190*	9.04 Profit of 8,046 on sale
2025-03-31	BUY	89	8.580*	9.14
2025-03-19	SELL	-178	9.840*	8.87 Profit of 1,579 on sale
2025-03-14	SELL	-534	9.430*	8.73 Profit of 4,660 on sale
2025-03-13	SELL	-178	9.000*	8.69 Profit of 1,547 on sale
2025-03-12	SELL	-3,026	8.900*	8.66 Profit of 26,214 on sale
2025-03-07	BUY	1,184	8.670*	8.50
2025-03-06	BUY	9,510	8.590*	8.47
2025-03-05	BUY	1,951	8.730*	8.34
2025-03-04	BUY	645	8.410*	8.27
2025-03-03	BUY	3,515	8.270*	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AVXL

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	292,950	350	493,091	59.4%
2025-09-18	292,461	730	632,664	46.2%
2025-09-17	238,968	0	344,719	69.3%
2025-09-16	124,131	0	203,931	60.9%
2025-09-15	327,284	620	495,734	66.0%
2025-09-12	188,856	9	297,912	63.4%
2025-09-11	283,057	43,129	512,801	55.2%
2025-09-10	755,725	40,238	1,047,179	72.2%
2025-09-09	651,589	1,000	1,103,832	59.0%
2025-09-08	191,294	0	265,507	72.0%
2025-09-05	130,504	50	260,693	50.1%
2025-09-04	258,462	0	360,127	71.8%
2025-09-03	237,765	2,728	362,191	65.6%
2025-09-02	249,450	100	378,631	65.9%
2025-08-29	238,966	375	388,448	61.5%
2025-08-28	209,977	2,300	320,987	65.4%
2025-08-27	232,736	0	330,617	70.4%
2025-08-26	104,349	1,056	307,622	33.9%
2025-08-25	205,172	2,500	283,898	72.3%
2025-08-22	168,634	0	247,739	68.1%
2025-08-21	193,437	1,834	320,019	60.4%
2025-08-20	170,915	0	218,615	78.2%
2025-08-19	281,852	19,391	450,833	62.5%
2025-08-18	254,587	432	358,911	70.9%
2025-08-15	282,594	80,843	392,702	72.0%
2025-08-14	327,006	9,894	473,515	69.1%
2025-08-13	310,944	1,019	479,075	64.9%
2025-08-12	518,863	2,020	696,657	74.5%
2025-08-11	223,214	0	368,082	60.6%
2025-08-08	207,053	2,314	312,375	66.3%
2025-08-07	265,030	12,385	393,458	67.4%
2025-08-06	153,741	721	216,786	70.9%
2025-08-05	243,764	2,107	326,215	74.7%
2025-08-04	252,173	0	402,479	62.7%
2025-08-01	247,327	210	384,957	64.2%
2025-07-31	461,281	2,762	698,484	66.0%
2025-07-30	225,848	423	354,251	63.8%
2025-07-29	188,747	0	337,746	55.9%
2025-07-28	548,153	3,543	1,342,139	40.8%
2025-07-25	366,868	27,091	609,405	60.2%
2025-07-24	949,021	1,733	1,541,426	61.6%
2025-07-23	830,143	3,752	1,267,314	65.5%
2025-07-22	156,882	807	309,603	50.7%
2025-07-21	172,877	1,716	267,374	64.7%
2025-07-18	196,465	1,022	268,450	73.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE